To say that Medical Marijuana, Inc. made headlines in 2016 would be an understatement. In reality, the company known for its CBD hemp oil products took the medical marijuana market by storm with product availability in all 50 states. Since its launch in 2012, MJNA‘s subsidiary company, HempMeds, has made it easier for patients around the country to access relief for a variety of medical issues without the debilitating side effects that often accompany traditional treatment methods. In 2015, the market for hemp products in the United States climbed to $573 million, and that figure is expected to increase dramatically over the next several years. According to estimates from the Hemp Business Journal, the market for CBD is expected to reach $2.1 billion by 2020.
MJNA’s Subsidiary Companies
MJNA‘s subsidiaries include HempMeds, Kannaway, HempMeds MX and HempMeds Brasil. Each of these subsidiaries serves a unique segment of the cannabis product market. As the CBD market continues to grow, with more states legalizing the use of medical and recreational marijuana each year, MJNA will continue to expand its target consumer base. The 2016 elections played a major role in this market growth, with states such as Arkansas, Florida, North Dakota and Montana voting to approve medical marijuana for some or all treatment indications.
One of the most exciting developments for MJNA at the beginning of 2017 is the permission HempMeds Mexico has received for its RSHO-X product line. RSHO-X products have received official COFEPRIS approval for the treatment of pain associated with cancer. This development came after a 44-year old woman who was diagnosed with Stage 5 breast cancer was issued approval to seek treatment from HempMeds Mexico. RSHO-X features a zero-THC cannabidiol formulation that provides relief for cancer-related pain without causing the high associated with other medical marijuana products. In addition to cancer treatment options, RSHO-X also shows promise as a treatment for many other conditions, including multiple sclerosis, Parkinson’s disease and depression.
HempMeds Brasil Growth
HempMeds Brasil has been globally recognized for its efforts to bring practical treatment solutions to the many patients in Brazil. The Brazilian subsidiary was the first company in the nation to distribute medicinal cannabis with the Brazilian government’s permission. The trusted products offered by HempMeds Brasil are known for providing measurable relief from symptoms of a variety of medical indications. A new import agreement allows all Brazilians with an approved medical indication to use RSHO products. From chronic pain to epilepsy, this means that doctors and patients in Brazil have more options when it comes to long-term treatment.
Why CBD Hemp Oil Products Work
Real Scientific Hemp Oil products work because they are scientifically formulated for reliability and consistency. No matter which concentration is chosen for a given treatment indication, RSHO’s varied delivery methods make it easy for patients to access the relief they need. Tinctures, salves, capsules and sublingual delivery systems provide variety for patients who have difficulty metabolizing treatment through one or more delivery methods. All CBD hemp oil used by MJNA and its subsidiaries is extracted using a specialized process that offers a high concentration of CBD oil without contaminants and fillers. Other beneficial nutrients and ingredients, such as amino acids and omega-3 fatty acids, are also found in each formulation, offering even greater health benefits. Because this hemp oil is so pure, it can be consumed through drops, oil and chewing gum. With promising research results related to the effectiveness of each of MJNA‘s hemp oil products in a medical setting, the company will be able to offer even more medical benefits to its international client base in the coming years.
About the Author
Stuart Smith is the CEO and Founder of SmallCapVoice.com. SmallCapVoice.com. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/